Evidence map›Paper›PMID 39379895›Full record

ArticleBMC medical imaging2024

Characteristics of

Mimi Xu, Yafei Zhang, Guangfa Wang, Lili Lin, Yan Wu, Yu Wang, Kui Zhao, Xinhui Su

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mimi Xu *Department of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Yafei Zhang *Department of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Guangfa WangDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Lili LinDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Yan WuDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Yu WangThe Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, China.
Kui ZhaoDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. zhaokui0905@zju.edu.cn.
Xinhui SuDepartment of Nuclear Medicine, The First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. suxinhui@zju.edu.cn.

Funding

The Science and Technology Plan Program of Traditional Chinese Medicine of Zhejiang Province 2024ZR093
6 · The paper itself

Abstract

background'Kimura's disease (KD) is a rare chronic inflammatory disorder of unknown etiology and is difficult to diagnose due to poor clinical presentation and imaging features. Few studies on characteristics of

methodsThe clinical data and

resultsThis study included 7 males and one female ranging in age from 17 to 79 years. The longest diameter of lesions ranged from 0.8 cm to 4.8 cm, and regional or generalized lymphadenopathy was found in all 8 patients with eosinophilia, while subcutaneous masses and salivary gland involvement concurrently were found in 4 patients.

conclusionsKimura's disease should be considered when

Indexed as

Fluorodeoxyglucose F18Kimura DiseasePositron Emission Tomography Computed TomographyRadiopharmaceuticalsAdolescentAdultAgedAngiolymphoid Hyperplasia with EosinophiliaChinaFemaleHumansMaleMiddle AgedRetrospective StudiesYoung AdultFluorodeoxyglucose F18Radiopharmaceuticals18F-FDGKimura’s diseasePET/CT

Identifiers

PMID39379895
PMCPMC11459994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.